Trial NCT04900038

View at ClinicalTrials.gov 
Org. Study IDs: 212483

Last trial update was posted on 2023-12-14

MeSH Interventions

Dolutegravir Lamivudine

MeSH Conditions

HIV Infections

Other Conditions


Stopping Reasons

Company decision to stop compound development. The decision was not based on any safety or efficacy concerns. It reflected the company strategy for portfolio progression.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID